Skip to main content
Home / Current Medicinal Chemistry, Volume 18, Number 13
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 18, Number 13, 2011

Articles

Free Content Editorial [Hot Topic: NAD and its Role in Biology and Medicine (Guest Editor: Krzysztof W. Pankiewicz)]
pp. 1890-1890(1)
Author: W. Pankiewicz, Krzysztof

Favourites:
ADD

Rehab of NAD(P)-Dependent Enzymes with NAD(P)-Based Inhibitors
pp. 1891-1908(18)
Authors: Felczak, K.; W. Pankiewicz, K.

Favourites:
ADD

The Antibiotic Potential of Prokaryotic IMP Dehydrogenase Inhibitors
pp. 1909-1918(10)
Authors: Hedstrom, L.; Liechti, G.; B. Goldberg, J.; R. Gollapalli, D.

Favourites:
ADD

Advances in Characterization of Human Sirtuin Isoforms: Chemistries, Targets and Therapeutic Applications
pp. 1919-1935(17)
Authors: Cen, Y.; Y. Youn, D.; A. Sauve, A.

Favourites:
ADD

Medicinal Chemistry of Sirtuin Inhibitors
pp. 1936-1946(11)
Author: Chen, L.

Favourites:
ADD

NAMPT in Regulated NAD Biosynthesis and its Pivotal Role in Human Metabolism
pp. 1947-1961(15)
Author: S. Burgos, E

Favourites:
ADD

NMNAT Expression and its Relation to NAD Metabolism
pp. 1962-1972(11)
Authors: N. Jayaram, H.; Kusumanchi, P.; A. Yalowitz, J.

Favourites:
ADD

NMN/NaMN Adenylyltransferase (NMNAT) and NAD Kinase (NADK) Inhibitors: Chemistry and Potential Therapeutic Applications
pp. 1973-1992(20)
Authors: Petrelli, R.; Felczak, K.; Cappellacci, L.

Favourites:
ADD

Significant Breakthroughs in Search for Anti-Infectious Agents Derived from Erythromycin A
pp. 1993-2015(23)
Authors: Ma, Xiaodong; Ma, Shutao

Favourites:
ADD

Endoplasmic Reticulum Stress Inhibition Enhances Liver Tolerance to Ischemia/Reperfusion
pp. 2016-2024(9)
Authors: Peralta, C.; Brenner, C.

Favourites:
ADD

Cyclin Dependent Kinase 1 Inhibitors: A Review of Recent Progress
pp. 2025-2043(19)
Authors: Wang, Q.; Su, L.; Liu, N.; Zhang, L.; Xu, W.; Fang, H.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content